J. Grosjean

943 total citations
20 papers, 762 citations indexed

About

J. Grosjean is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, J. Grosjean has authored 20 papers receiving a total of 762 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in J. Grosjean's work include NF-κB Signaling Pathways (6 papers), Acute Myeloid Leukemia Research (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). J. Grosjean is often cited by papers focused on NF-κB Signaling Pathways (6 papers), Acute Myeloid Leukemia Research (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). J. Grosjean collaborates with scholars based in France and United Kingdom. J. Grosjean's co-authors include Pierre Fenaux, Guido Kroemer, Claire Fabre, Thomas Braun, Lionel Adès, Éric Galin, Stéphane Mérillou, Adrien Peytavie, Ewa Paleolog and Simone Boehrer and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Oncogene.

In The Last Decade

J. Grosjean

19 papers receiving 744 citations

Peers

Countries citing papers authored by J. Grosjean

Since Specialization

Citations

This map shows the geographic impact of J. Grosjean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Grosjean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Grosjean more than expected).

Fields of papers citing papers by J. Grosjean

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Grosjean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Grosjean. The network helps show where J. Grosjean may publish in the future.

Co-authorship network of co-authors of J. Grosjean

This figure shows the co-authorship network connecting the top 25 collaborators of J. Grosjean. A scholar is included among the top collaborators of J. Grosjean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Grosjean. J. Grosjean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Human cytomegalovirus quantification in toddlers saliva from day care centers and emergency unit: A feasibility study 2014 ·Journal of Clinical Virology ·J. Grosjean, (unknown), Sébastien Hantz, Catherine Mengelle, (unknown), (unknown), (unknown), F. Denis, Benôıt Marin, (unknown)	23
2	Accidental potassium dichromate poisoning. Toxicokinetics of chromium by ICP-MS-CRC in biological fluids and in hair 2011 ·Forensic Science International ·Jean‐Pierre Goullé, Élodie Saussereau, J. Grosjean, Christophe Doche, Loïc Mahieu, (unknown), Michel Guerbet, Christian Lacroix	20
3	Direct genotyping of cytomegalovirus envelope glycoproteins from toddler's saliva samples 2009 ·Journal of Clinical Virology ·J. Grosjean, Sébastien Hantz, (unknown), (unknown), Catherine Mengelle, (unknown), (unknown), (unknown), P. Brosset, Christophe Pasquier, F. Denis, Sophie Alain	22
4	Procedural Generation of Rock Piles using Aperiodic Tiling 2009 ·Computer Graphics Forum ·Adrien Peytavie, Éric Galin, J. Grosjean, Stéphane Mérillou	28
5	Arches: a Framework for Modeling Complex Terrains 2009 ·Computer Graphics Forum ·Adrien Peytavie, Éric Galin, J. Grosjean, Stéphane Mérillou	71
6	A novel effect of DNA methyltransferase and histone deacetylase inhibitors : NFκB inhibition in malignant myeloblasts 2008 ·Cell Cycle ·Claire Fabre, J. Grosjean, Maximilien Tailler, Simone Boehrer, Lionel Adès, Jean‐Luc Perfettini, Stéphane de Botton, Pierre Fenaux, Guido Kroemer	41
7	Unexpected substitution of dominant rotavirus G genotypes in French hospitalized children over five consecutive seasons 2008 ·European Journal of Clinical Microbiology & Infectious Diseases ·Alexis de Rougemont, Jérôme Kaplon, Pierre Lebon, Frédéric Huet, F. Denis, Sophie Alain, (unknown), J. Grosjean, (unknown), D Gendrel, Pierre Pothier	21
8	Differentiating megakaryocytes in myelodysplastic syndromes succumb to mitochondrial derangement without caspase activation 2007 ·APOPTOSIS ·Thorsten Braun, Gabrielle Carvalho, J. Grosjean, Lionel Adès, Claire Fabre, Simone Boehrer, Najet Debili, Pierre Fenaux, Guido Kroemer	7
9	NF-κB inhibition sensitizes to starvation-induced cell death in high-risk myelodysplastic syndrome and acute myeloid leukemia 2007 ·Oncogene ·Claire Fabre, (unknown), Ezgi Tasdemir, Thomas Braun, Lionel Adès, J. Grosjean, Simone Boehrer, David Métivier, Sylvie Souquère, Gérard Pierron, Pierre Fenaux, Guido Kroemer	79
10	Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical study 2007 ·Blood ·Simone Boehrer, Lionel Adès, Thorsten Braun, Lorenzo Galluzzi, J. Grosjean, Claire Fabre, Geneviève Roux, Claude Gardin, Antoine Martin, Stéphane de Botton, Pierre Fenaux, Guido Kroemer	93
11	Flt3 Receptor Inhibition Abolishes Constitutive NFκB Activation in High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia. 2007 ·Blood ·J. Grosjean, Lionel Adès, (unknown), Pierre Fenaux, Guido Kroemer	15
12	Disruption of Bcl-2 Heterodimerization by the BH3 Mimetic ABT-737 Restores Spontaneous Apoptosis and Induces Differentiation in High Risk MDS and AML. 2007 ·Blood ·Lionel Adès, Simone Boehrer, Thorsten Braun, J. Grosjean, Claire Fabre, Pierre Fenaux, Guido Kroemer	1
13	Targeting NF-κB in hematologic malignancies 2006 ·Cell Death and Differentiation ·Thomas Braun, (unknown), Claire Fabre, J. Grosjean, Pierre Fenaux, Guido Kroemer	137
14	Inhibition of NEMO, the regulatory subunit of the IKK complex, induces apoptosis in high-risk myelodysplastic syndrome and acute myeloid leukemia 2006 ·Oncogene ·(unknown), Claire Fabre, Thomas Braun, J. Grosjean, Lionel Adès, Fabrice Agou, Ezgi Tasdemir, Simone Boehrer, Alain Israël, M. Véron, Pierre Fenaux, Guido Kroemer	40
15	Cyclooxygenase-2 Induction and Prostacyclin Release by Protease-activated Receptors in Endothelial Cells Require Cooperation between Mitogen-activated Protein Kinase and NF-κB Pathways 2006 ·Journal of Biological Chemistry ·Farisa Syeda, J. Grosjean, Rebecca A. Houliston, Rosemary J. Keogh, Tom Carter, Ewa Paleolog, Caroline Wheeler‐Jones	83
16	Vascular endothelial growth factor signalling in endothelial cell survival: A role for NFκB 2005 ·Biochemical and Biophysical Research Communications ·J. Grosjean, Serafim Kiriakidis, (unknown), Marc Feldmann, Ewa Paleolog	62
17	EFFECTS OF CHYLOMICRON REMNANT-LIKE PARTICLES ON VASCULAR ENDOTHELIUM AND SMOOTH MUSCLE 2004 ·Cardiovascular Pathology ·Michelle Evans, (unknown), Kathleen M. Botham, Jonathan Elliott, J. Grosjean, Ewa Paleolog, Caroline Wheeler‐Jones	1
18	THE ROLE OF THE NFκB PATHWAY IN ATHEROSCLEROSIS 2004 ·Claudia Monaco, J. Grosjean, Ewa Paleolog	0
19	Angiogenesis and arthritis: a potential therapeutic target? 2004 ·Arthritis Research ·J. Grosjean, (unknown), Ewa Paleolog	1
20	Evaluation of the Command and Control Cube 2003 ·J. Grosjean, Jean‐Marie Burkhardt, Sabine Coquillart, (unknown)	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact